ReviewFrontiers in pharmacology2026
Efficacy and safety of common Chinese herbal medicines in treating psoriasis: a systematic review and meta-analysis.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clove (Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Psoriasis is a common chronic inflammatory skin disease with a high incidence, imposing a substantial global disease burden. As a low-cost complementary and alternative therapy, traditional Chinese herbal formulations have been widely used in clinical practice in China for the treatment of psoriasis. However, systematic analyses of their application value based on traditional Chinese medicine (TCM) syndrome patterns or treatment outcomes remain relatively limited. Objective: We aim to systematically assess the efficacy and safety of common traditional Chinese herbs in the treatment of patients with psoriasis. Methods: We conducted a systematic literature search in PubMed, Web of Science, SciFinder, WanFang Database, and China National Knowledge Infrastructure (CNKI). The literature meeting the predefined inclusion criteria was subjected to a secondary screening process. Meta-analysis was subsequently conducted using Review Manager software (version 5.4.1). Results: A total of 47 papers involving 3,675 patients were included in the study. All TCM (herbal formula) groups showed positive effects in enhancing the treatment efficiency of different types of psoriasis. In particular, herbal medicines had a more considerable role in managing arthropathic psoriasis compared to other types of psoriasis. In terms of reducing Psoriasis Area and Severity Index (PASI) scores, TCM formula treatment showed marked benefits in pustular psoriasis. As for the improvement in TCM symptom indicators, patients with erythrodermic psoriasis (EP) showed better efficacy. For psoriasis accompanied by blood dryness, herbal medicines were more effective in reducing Dermatology Life Quality Index (DLQI) scores. Conclusion: The results indicate that TCM formulations included in this review are beneficial for reducing PASI scores, DLQI scores, and TCM symptom scores among patients with different types of psoriasis. The most commonly used herbal formula was Blood cooling and detoxification formula, followed by Taohong Siwu decoction and Blood nourishing and detoxifying formula. Nevertheless, more rigorously designed studies on herbal medicines are warranted to enhance the overall quality of research in this field going forward.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.